Literature DB >> 22987147

Evaluation of a prospective surgical strategy of extended resection to achieve R0 status in gall bladder cancer.

Biju Pottakkat1, Abhimanyu Kapoor, Anand Prakash, Rajneesh Kumar Singh, Anu Behari, Ashok Kumar, Vinay K Kapoor, Rajan Saxena.   

Abstract

INTRODUCTION: Radical resection to achieve R0 status remains the only potential curative option in patients with gall bladder cancer (GBC). This study was aimed to evaluate the efficacy of an extended criterion of radical resection to achieve R0 status in GBC.
METHODS: A triple-phase CT with 3D reconstruction was done in all patients. A standard resectability criterion was followed in all patients. A minimum of liver segment 4B + 5 resection and radical lymphadenectomy including the para-aortic areas were undertaken in all patients. Adjacent organectomy was added as required.
RESULTS: Between November 2008 and April 2011, 59 patients with GBC underwent operation and 40 (resectability, 68 %) underwent resection. The resectional procedures performed were segmentectomy 4B + 5 in 31 (78 %), median sectorectomy in 2 (5 %), extended right hepatectomy in 3 (8 %), and hepatopancreaticoduodenectomy in 4 (10 %) patients. Postoperative complications occurred in 24 (60 %) patients. Two patients died postoperatively. A total of 829 lymph nodes were harvested and the median lymph node count was 18 (4-77). Twenty-three (58 %) patients had lymph node metastases. Twenty-eight of 40 (70 %) had disease limited till N1 nodes. Metastases up to N2 lymph nodes were seen in 12 (30 %). American Joint Committee on Cancer seventh edition stages were I-2 (5 %) patients, II-5 (13 %), III-19 (48 %), and IV-14 (35 %). R0 resection was achieved in 33 (83 %) patients. Four patients had recurrence and one died of recurrence. All other patients are alive till the last follow-up.
CONCLUSIONS: Assessment with triple-phase CT with 3D reconstruction can produce high resectability rate in GBC. Extended criterion of radical resection results in R0 status in more than 80 % of patients with GBC.

Entities:  

Mesh:

Year:  2013        PMID: 22987147     DOI: 10.1007/s12029-012-9432-z

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  31 in total

1.  Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries.

Authors:  Jean M Butte; Kenichi Matsuo; Mithat Gönen; Michael I D'Angelica; Enrique Waugh; Peter J Allen; Yuman Fong; Ronald P DeMatteo; Leslie Blumgart; Itaru Endo; Hernán De La Fuente; William R Jarnagin
Journal:  J Am Coll Surg       Date:  2010-11-12       Impact factor: 6.113

2.  Adequate extent in radical re-resection of incidental gallbladder carcinoma: analysis of the German Registry.

Authors:  Thorsten Oliver Goetze; Vittorio Paolucci
Journal:  Surg Endosc       Date:  2010-02-23       Impact factor: 4.584

3.  Identification of the regional lymphatic system of the gallbladder by vital staining.

Authors:  Y Shirai; K Yoshida; K Tsukada; T Ohtani; T Muto
Journal:  Br J Surg       Date:  1992-07       Impact factor: 6.939

4.  Role of regional lymphadenectomy in different stage of gallbladder carcinoma.

Authors:  Jian-Dong Wang; Ying-Bin Liu; Zhi-Wei Quan; Song-Gang Li; Xue-Feng Wang; Jun Shen
Journal:  Hepatogastroenterology       Date:  2009 May-Jun

5.  Appraisal of surgical resection of gallbladder cancer with special reference to lymph node dissection.

Authors:  H Shimada; I Endo; Y Fujii; N Kamiya; H Masunari; O Kunihiro; K Tanaka; K Misuta; S Togo
Journal:  Langenbecks Arch Surg       Date:  2000-12       Impact factor: 3.445

6.  Direct lymphatic spreading route into the liver from the gallbladder: an animal experiment using pig.

Authors:  Toshihide Terazawa; Hidenori Miyake; Miho Kurahashi; Seiki Tashiro
Journal:  J Med Invest       Date:  2004-08

7.  Aggressive surgery for stage IV gallbladder carcinoma; what are the contraindications?

Authors:  Hideki Nishio; Masato Nagino; Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Yuji Nimura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-07-30

8.  Hepatic resection combined with portal vein or hepatic artery reconstruction for advanced carcinoma of the hilar bile duct and gallbladder.

Authors:  Hiroshi Shimada; Itaru Endo; Mitsutaka Sugita; Hideki Masunari; Yoshiro Fujii; Kuniya Tanaka; Koichi Misuta; Hitoshi Sekido; Shinji Togo
Journal:  World J Surg       Date:  2003-08-21       Impact factor: 3.352

9.  Hepatectomy of segment 4a and 5 combined with extra-hepatic bile duct resection for T2 and T3 gallbladder carcinoma.

Authors:  Naohiko Kohya; Kohji Miyazaki
Journal:  J Surg Oncol       Date:  2008-05-01       Impact factor: 3.454

10.  A curative resection improves the postoperative survival rate even in patients with advanced gallbladder carcinoma.

Authors:  Masahiro Kai; Kazuo Chijiiwa; Jiro Ohuchida; Motoaki Nagano; Masahide Hiyoshi; Kazuhiro Kondo
Journal:  J Gastrointest Surg       Date:  2007-08       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.